Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Exelon Patch 10
Active Ingredient: Rivastigmine 18mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: Exelon Patch 15
Active Ingredient: Rivastigmine 27mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: Exelon Patch 20
Active Ingredient: Rivastigmine 36mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: Exelon Patch 5
Active Ingredient: Rivastigmine 9mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: m-Chloramphenicol
Active Ingredient: Chloramphenicol 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: FDC Limited, B-8, M I D C Industrial Estate, Waluj, District Aurangabad, India
Dated this 10th day of August 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).